We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Affiliated Managers Group
AMG
$10.2B
| $231K | ﹤0.01% |
1,622
-754
| -32% | -$119K |
|
1552
Columbia Banking Systems
COLB
$9.06B
| $231K | ﹤0.01% |
+10,777
| New | +$299K |
|
1553
CALL
Thermo Fisher Scientific
TMO
$209B
| $231K | ﹤0.01% |
+400
| New | +$225K |
|
1554
Seaboard Corp
SEB
$4.17B
| $230K | ﹤0.01% |
+61
| New | +$236K |
|
1555
PUT
Lamb Weston
LW
$7.3B
| $230K | ﹤0.01% |
2,200
-2,000
| -48% | -$198K |
|
1556
CALL
Intuitive Surgical
ISRG
$129B
| $230K | ﹤0.01% |
900
-1,700
| -65% | -$419K |
|
1557
Leggett & Platt
LEG
$1.41B
| $230K | ﹤0.01% |
7,212
-6,262
| -46% | -$211K |
|
|
SIX
1558
DELISTED
Six Flags Entertainment Corp.
SIX
| $230K | ﹤0.01% |
+8,598
| New | +$230K |
|
1559
IBEX
IBEX
$482M
| $229K | ﹤0.01% |
+9,400
| New | +$251K |
|
1560
BILL Holdings
BILL
$4.78B
| $229K | ﹤0.01% |
2,818
-5,637
| -67% | -$523K |
|
|
GMS
1561
DELISTED
GMS Inc
GMS
| $227K | ﹤0.01% |
+3,927
| New | +$222K |
|
1562
West Pharmaceutical
WST
$24.4B
| $227K | ﹤0.01% |
+655
| New | +$191K |
|
1563
Acuity Brands
AYI
$10.3B
| $227K | ﹤0.01% |
1,241
-553
| -31% | -$102K |
|
1564
News Corp Class B
NWS
$17.3B
| $227K | ﹤0.01% |
+13,010
| New | +$240K |
|
1565
Kornit Digital
KRNT
$771M
| $227K | ﹤0.01% |
+11,706
| New | +$264K |
|
1566
PUT
MGM Resorts International
MGM
$11.6B
| $227K | ﹤0.01% |
5,100
-5,000
| -50% | -$208K |
|
1567
CALL
Steel Dynamics
STLD
$37.6B
| $226K | ﹤0.01% |
+2,000
| New | +$233K |
|
|
NBIS
1568
Nebius Group N.V.
NBIS
$57.2B
| $225K | ﹤0.01% |
11,893
| – | – |
|
1569
JD.com
JD
$44.4B
| $225K | ﹤0.01% |
5,126
-1,245
| -20% | -$64.3K |
|
1570
SkinHealth Systems
SKIN
$96.1M
| $225K | ﹤0.01% |
+17,800
| New | +$206K |
|
|
VTYX
1571
DELISTED
Ventyx Biosciences
VTYX
| $225K | ﹤0.01% |
+6,708
| New | +$261K |
|
1572
Cal-Maine
CALM
$3.98B
| $224K | ﹤0.01% |
3,678
-20,674
| -85% | -$1.15M |
|
1573
PUT
Teva Pharmaceuticals
TEVA
$39.9B
| $224K | ﹤0.01% |
25,300
| – | – |
|
|
FRC
1574
CALL
DELISTED
First Republic Bank
FRC
| $224K | ﹤0.01% |
+16,000
| New | +$1.64M |
|
1575
PUT
Wynn Resorts
WYNN
$10.2B
| $224K | ﹤0.01% |
2,000
-1,800
| -47% | -$188K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.